TENOFOVIR DISOPROXIL FUMARATE | A078800 | CIPLA LTD
Total Spending
$19.7M
Total Claims
78,659
Beneficiaries
15,480
Avg Cost/Unit
$4.97
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
26 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| May 6, 2009 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.